- Home
- KOSS vs MRNS Comparison
KOSS vs MRNS Comparison
Compare KOSS & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- MRNS
- Stock Information
- Founded
- KOSS 1953
- MRNS 2003
- Country
- KOSS United States
- MRNS United States
- Employees
- KOSS N/A
- MRNS N/A
- Industry
- KOSS Consumer Electronics/Appliances
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- MRNS Health Care
- Exchange
- KOSS Nasdaq
- MRNS Nasdaq
- Market Cap
- KOSS 63.0M
- MRNS 104.7M
- IPO Year
- KOSS N/A
- MRNS 2014
- Fundamental
- Price
- KOSS $7.34
- MRNS $0.31
- Analyst Decision
- KOSS
- MRNS Buy
- Analyst Count
- KOSS 0
- MRNS 12
- Target Price
- KOSS N/A
- MRNS $4.56
- AVG Volume (30 Days)
- KOSS 183.8K
- MRNS 5.7M
- Earning Date
- KOSS 11-08-2024
- MRNS 11-05-2024
- Dividend Yield
- KOSS N/A
- MRNS N/A
- EPS Growth
- KOSS N/A
- MRNS N/A
- EPS
- KOSS N/A
- MRNS N/A
- Revenue
- KOSS $12,265,069.00
- MRNS $30,263,000.00
- Revenue This Year
- KOSS N/A
- MRNS $21.18
- Revenue Next Year
- KOSS N/A
- MRNS $56.42
- P/E Ratio
- KOSS N/A
- MRNS N/A
- Revenue Growth
- KOSS N/A
- MRNS 16.56
- 52 Week Low
- KOSS $2.27
- MRNS $0.26
- 52 Week High
- KOSS $18.73
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- KOSS 50.17
- MRNS 21.75
- Support Level
- KOSS $7.00
- MRNS $0.29
- Resistance Level
- KOSS $7.83
- MRNS $1.96
- Average True Range (ATR)
- KOSS 0.44
- MRNS 0.12
- MACD
- KOSS -0.01
- MRNS -0.18
- Stochastic Oscillator
- KOSS 32.26
- MRNS 2.41
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.